Emerging drugs for hepatic encephalopathy (Q37529838)

20 August 2017

1 reference

title

Emerging drugs for hepatic encephalopathy (English)

1 reference

20 August 2017

Oliviero Riggio

1

1 reference

PubMed ID

19552607

20 August 2017

Lorenzo Ridola

series ordinal

2

1 reference

PubMed ID

19552607

20 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Expert Opinion on Emerging Drugs

20 August 2017

1 reference

20 August 2017

14

1 reference

20 August 2017

3

1 reference

20 August 2017

537-549

1 reference

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

20 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Characteristics of minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Screening of subclinical hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Minimal hepatic encephalopathy matters in daily life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Patients with minimal hepatic encephalopathy have poor insight into their driving skills

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Review: surgical shunts and encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

New concepts in the mechanism of ammonia-induced astrocyte swelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Pathogenetic mechanisms of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Mouse genetics at work: a new model of chronic hepadnavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

21 January 2018

Hepatic Encephalopathy.

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Probiotic yogurt for the treatment of minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Inhibitory control test for the diagnosis of minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

ESPEN Guidelines on Enteral Nutrition: Liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Embolization of portal-systemic shunts in cirrhotic patients with chronic recurrent hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Chronic portosystemic encephalopathy: embolization of portosystemic shunts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

EWI-2wint--a host cell factor inhibiting hepatitis C virus entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

The treatment of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

A randomized controlled trial of acarbose in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Identification and measurement of oxindole (2-indolinone) in the mammalian brain and other rat organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Interorgan ammonia trafficking in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Survival after treatment with phenylacetate and benzoate for urea-cycle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Chronic hyperammonemia alters motor and neurochemical responses to activation of group I metabotropic glutamate receptors in the nucleus accumbens in rats in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903055067

10.1517/14728210903055067

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19552607